Posted on March 25, 20263/25/26
Solving The Rare Disease Launch Paradox — Using Pre‑Launch Planning and Partnership to Create Value
Posted on February 10, 20262/10/26
Rewiring Commercialization for Biotech’s New Reality
Posted on January 30, 20261/30/26
Bringing a Breakthrough Rare Disease Therapy to Market with Rapid Speed for Patients
Posted on January 27, 20261/27/26
Insights from Frontiers Health 2025: The Future of Commercialization Models
Posted on January 20, 20261/20/26
“Nothing changes if nothing changes.”
Posted on November 24, 202511/24/25
Brave New Commercialisation World
Posted on October 31, 202510/31/25
AI in Oncology: Acceleration, Accessibility, and Accuracy
Posted on August 27, 20258/27/25
“Nothing changes if nothing changes.”
Posted on May 22, 20255/22/25
Transformative Commercialization for New BioPharma Entrants Ensuring Success with Capital and Time Efficiency
Posted on May 22, 20255/22/25